Mobile heart‑health outreach to prevent heart failure in Detroit
ACHIEVE P2 - HF
This project tries bringing blood‑pressure control and heart‑protecting medicines directly into Detroit neighborhoods to prevent heart failure in adults, especially Black residents.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wayne State University NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project ID | NIH-11134419 on NIH RePORTER |
What this research studies
You would be invited to receive care from a mobile health unit that visits neighborhoods identified as highest need using local health data. The team focuses on controlling blood pressure and starting guideline‑recommended medicines that lower heart failure risk, including SGLT2 inhibitors when appropriate. Eligible people will be randomly assigned to get the mobile outreach or continue usual care so researchers can compare outcomes. The study follows participants over time to see whether improved access and medication use reduce new cases of heart failure.
Who could benefit from this research
Good fit: Adults (21 and older) in the Detroit area with high blood pressure or at high risk for heart failure—especially Black adults—are the ideal candidates.
Not a fit: People under 21, those who live outside the areas served by the mobile units, or individuals without high blood pressure are unlikely to benefit from this specific program.
Why it matters
Potential benefit: If successful, this approach could improve blood‑pressure control, increase use of medicines that prevent heart failure, and reduce racial health disparities in Detroit.
How similar studies have performed: SGLT2 inhibitor drugs have already been shown to lower heart‑failure risk in clinical trials, but using mobile units and geospatial targeting to deliver these therapies to underserved neighborhoods is a newer approach.
Where this research is happening
Detroit, United States
- Wayne State University — Detroit, United States (Active)
Researchers
- Principal investigator: Lanfear, David E — Wayne State University
- Study coordinator: Lanfear, David E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.